Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 11,500 shares at $345.79 ($4.0M) on 2023-08-10, disclosed to the SEC on 2023-08-14.
Scheduled sale ($4.0M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $345.79 | 5,750 | $2.0M | 50.0% |
| 2 | $345.79 | 5,750 | $2.0M | 50.0% |
| Total | $345.79 avg | 11,500 | $4.0M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |